Delivery Order SPE2DB20D1109-SPE2DB24FP77D

Award Date 8/23/24
Potential Completion Date 8/26/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,909.95 for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award, valued at $9,092.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,937.02, is for the delivery of 4564617016 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 16, 2024. The contract is not designated with any set-aside requirements. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,018.27, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a performance period ending on March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,240.97 Firm Fixed Price Delivery Order contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,252.78, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract is a Delivery Order with a Firm Fixed Price valued at $2,574.74, with a completion date of December 19, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a child of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,244.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 22, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB24FN46H, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, with a firm fixed price of $17,345.67 and a completion date of January 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, with the ID SPE2DB22D1002|SPE2DB24FLFM6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,387.61 Firm Fixed Price contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP77D
    Delivery Order

This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP77D, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,389.97, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product.

The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of August 26, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating open competition.

In addition to this specific contract, Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 12:13 PM